BPC-157: Extensively studied in preclinical models but remains investigational
Insurance does not cover peptide therapy
When properly reconstituted with BAC water and stored consistently between 2C and 8C (36F 46F), retatrutide is generally stable for up to 4 weeks
It is contraindicated in certain conditions such as active malignancy and must be used cautiously in those with diabetes, prediabetes, or a history of pituitary disease, which is why careful screening and regular monitoring are essential
Brain swelling occurs because fluid builds up in or around the brain tissue, which can create dangerous pressure inside the skull
References to biological effects are limited to research context only and must not be interpreted as claims of therapeutic, diagnostic, or clinical benefit